Control group N = 20 | HD patients N = 80 | P | HCV – ve HD N = 40 | HCV + ve HD N = 40 | P | |
---|---|---|---|---|---|---|
Demographic data | ||||||
Gender (male ♂/female♀] | 11/9 | 49/31 | NS | 27/13 | 22/18 | NS |
Age “years” | 31.55 ± 11.02 | 52.26 ± 12.28 | < 0.001 | 51.42 ± 2.14 | 53.10 ± 1.73 | NS |
HD duration “years” | 0 | 3.55 ± 3.608 | < 0.001 | 2.20 ± 0.41 | 4.90 ± 0.63 | P < 0.001 |
Clinical profile | ||||||
Creatinine “mg/dl” | 0.78 ± 0.14 | 5.37 ± 2.54 | < 0.01 | 4.28 ± 0.39 | 6.46 ± 0.33 | P < 0.001 |
Urea “mg/dl” | 24.7 ± 7.81 | 176.18 ± 78.75 | P < 0.001 | 144.70 ± 12.50 | 207.65 ± 10.33 | P < 0.001 |
Sodium “mmol/l” | 143.65 ± 4.82 | 152.64 ± 140.68 | P < 0.001 | 169.97 ± 31.24 | 135.30 ± 3.26 | NS |
Potassium “mmol/l” | 3.83 ± 0.35 | 6.52 ± 1.62 | NS | 6.00 ± 0.21 | 7.04 ± 0.26 | P < 0.001 |
ALT “u/l” | 16.7 ± 3.64 | 23.51 ± 7.62 | P < 0.001 | 22.35 ± 1.10 | 24.67 ± 1.28 | NS |
AST “u/l” | 17.45 ± 3.87 | 33.13 ± 10.55 | P < 0.001 | 34.22 ± 1.56 | 32.02 ± 1.77 | NS |
Albumin “g/dl” | 4.05 ± 0.29 | 3.89 ± 0.38 | P < 0.001 | 4.03 ± 0.06 | 3.75 ± 0.04 | NS |
Total bilirubin “mg/dl” | 0.65 ± 0.13 | 0.84 ± 0.25 | NS | 0.69 ± 0.02 | 0.98 ± 0.04 | P < 0.01 |